Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance (Q67761429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

main subject

irritable bowel syndrome

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

13 November 2022

author name string

C. Lunardi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

L. M. Bambara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

D. Biasi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

P. Cortina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

P. Peroli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

F. Nicolis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

F. Favari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

M. L. Pacor

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1742648

13 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1742648

13 November 2022

publication date

1 September 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2222.1991.tb00848.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.1991.tb00848.x/fullpdf

13 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Clinical & Experimental Allergy

13 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

569-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

Irritable bowel syndrome: classification and pathogenesis

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Organic and functional disorders in 2000 gastroenterology outpatients

13 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Controlled study of psychotherapy in irritable bowel syndrome

13 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome

13 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Hypnotherapy in severe irritable bowel syndrome: further experience

13 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Wheat fibre and irritable bowel syndrome. A controlled trial

13 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

The Quarterly Journal of Medicine

13 November 2022

9

99

259

Lessof MH

1980

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome

13 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Food hypersensitivity in irritable bowel syndrome

13 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Specific food intolerance: its place as a cause of gastrointestinal symptoms

13 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Food intolerance and the irritable bowel syndrome

13 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Gastrointestinal permeability in children with cow's milk allergy: effect of milk challenge and sodium cromoglycate as assessed with polyethyleneglycols (PEG 400 and PEG 1000)

13 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Oral cromolyn in food allergy: in vivo and in vitro effects

13 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Oral and inhaled sodium cromoglycate in challenge test with food allergens or acetylsalicylic acid

13 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity

13 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

A study of hypoallergenic diets and oral sodium cromoglycate in the management of atopic eczema

13 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Prostaglandin-synthesis inhibitors in prophylaxis of food intolerance

13 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Advances in prostaglandin and thromboxane research

13 November 2022

27

8

1627

Bukhave K

1980

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

Immune complexes containing food proteins in normal and atopic subjects after oral challenge and effect of sodium cromoglycate on antigen absorption

13 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1991.TB00848.X

13 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742648%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference